PubMed HealthSearch

Biomedical subjects

A Perales

Publications and source records attributed to A Perales.

11 recordsLinked to original sources

Prospective double-arm study of fibrinolysis in surgical patients.

BACKGROUND: During surgery, the balance between thrombosis and fibrinolysis is altered. Methods reported to increase fibrinolysis, such as compression devices, may reduce venous thrombosis. However, there are no prospective studies comparing methods and the effect on fibrinolysis. MATERIALS AND METHODS: In a prospective study, general surgical patients were randomized to either sequential compression devices (Group 1) or subcutaneous heparin (Group 2), and fibrinolysis factors were measured in order to determine the effect on the fibrinolysis system. Blood samples were drawn at a similar time of the day with the tourniquet off. Specifically, t-PA antigen, plasminogen activator inhibitor-1 (PAI-1), and D-dimer were measured preoperatively (preop) and on Postoperative Days (POD) 1 and 7 by the ELISA method. Fibrinolysis factors were reported as the mean +/- SD and as percentage change from preoperative values. Noninvasive vascular studies were performed preop, and on POD 1, 7, and 30, by an examination of the infrainguinal venous system and external iliac veins in bilateral lower extremities. Nonambulatory patients were excluded from the study and DVT prophylaxis methods were initiated at surgery and used through POD 2. RESULTS: For the 136 patients in the study, there were no differences in clinical characteristics such as age, surgical time (all > 60 min), anesthesia type (general or spinal), type of surgical procedure, or other risk factors for DVT. Two DVTs occurred at POD 1 and 30 (both Group 2), and one pulmonary embolism in each group (POD 7 for Group 1; POD 1 for Group 2). For subjects without thrombosis, D-dimer changes were parallel for both groups, increasing through POD 7. Similarly, t-PA antigen levels rose from baseline on POD 1 in both groups, with a return toward baseline by POD 7. The PAI-1 levels increased on POD 1 in both groups, but severalfold more in Group 1 (compression devices). The elevation in PAI-1 decreased by 50% in Group 1 by POD 7, while values returned to normal in Group 2. These changes were not significant using the Mann-Whitney test. Only three patients had thrombotic episodes so that data on changes in fibrinolysis factors are difficult to compare with the larger group. CONCLUSIONS: This is the first report of a prospective, randomized comparison of fibrinolysis factors using sequential compression devices in comparison to low dose unfractionated heparin in general surgical patients, and comparing postoperative values to preop. Both groups showed an enhanced fibrinolysis by elevation in t-PA antigen and D-dimer on POD 1, as expected when fibrinolysis occurs. While PAI-1 and t-PA work in parallel, the marked elevation of PAI-1 on POD 1 (although only slightly above reference values) and continuing into POD 7 for subjects using compression devices requires further inquiry. The elevation of PAI-1 in the face of elevated t-PA and D-dimer has been reported, but the comparison between patients using sequential compression devices and mini-dose heparin has not been reported. The reason for the elevation requires additional study into other influences on the synthesis, secretion, and/or function of PAI-1 that do not affect t-PA.

Female

Is DVT prophylaxis overemphasized? A randomized prospective study.

This study was designed to prospectively evaluate a previously published prognostic index for predicting deep venous thrombosis (DVT) in general surgical patients with conventional prophylaxis. Patients undergoing procedures of at least 1 hr duration (abdominal, thoracic, head and neck, inguinal) requiring general or spinal anesthetic were prospectively randomized into the following groups: Group 1, sequential pneumatic compression devices during surgery and 2 days postoperatively; Group 2, subcutaneous heparin (5000 U q 12 hr) starting 1 hr before surgery and for 7 days postop; Group 3, control group. All patients underwent duplex evaluation of bilateral lower extremity deep venous systems preoperatively and on postoperative Days 1, 3, and 30. In addition, a previously developed predictive DVT incidence indicator, the prognostic index (PI), was calculated for each patient. A total of 137 patients were entered into the study with 29 removed for patient/staff reasons. There were no differences in PI among the three groups at the 0.05 level (ANOVA). The distribution of risk factors for DVT including increased age, body size, hemoglobin (Hb), and colorectal procedures were distributed evenly among the groups. Additional factors such as diabetes, COPD, PVD, immobilization, and cancer were also evenly distributed among the groups. The PI predicted a 20% incidence of DVT. For Groups 1 (n = 25), 2 (n = 38), and 3 (n = 45) no DVTs were detected over the 30 days of study. During the study period, 8 DVTs were detected by duplex evaluation in general surgical patients not in the study (1.5%). In conclusion, in a prospective randomized study using sequential pneumatic compression devices, subcutaneous heparin or no prophylaxis in matched general surgical patients at moderate to high risk for thromboembolism, no DVTs occurred for up to 30 days. Furthermore, neither a PI nor other factors associated with DVT accurately predicted the incidence of DVT in this patient population.

Adult

Immunoprophylaxis of caprine contagious agalactia due to Mycoplasma agalactiae with an inactivated vaccine.

The aim of this study was to control endemic contagious agalactia due to Mycoplasma agalactiae in a semi-extensive goat herd by means of vaccination with an inactivated vaccine. Groups of 400 goats were vaccinated one month before and three months after parturition (group A), one month before and four months after parturition (group B), and two months and one month before and three months after parturition (group C). The experiment continued over six lactations and natural infections were monitored clinically, immunologically and microbiologically. After the sixth lactation there were no significant clinical differences between these two groups and group C. The levels of growth-inhibiting antibodies ranged from 1:20 to 1:80 in groups A and B and from 1:40 to 1:160 in group C. The numbers of goats excreting mycoplasmas decreased to a greater extent in group C than in groups A and B. A natural infection induced an outbreak of contagious agalactia in group B. An experimental infection with 10(6) cfe affected seven of 10 goats in group A (two seriously) and two goats in group C moderately. It is recommended that three doses of vaccine should be administered before, and one dose after each parturition, and that the herd should be kept isolated in order to control the disease.

Animals

Effects of calcium entry blockers on KCl- and 5-hydroxytryptamine-induced contractions of human umbilical arteries.

The effects of Ca2+ removal and of the calcium entry blockers, nicardipine and nifedipine, on contractions of isolated human umbilical arteries, elicited with KCl and 5-hydroxytryptamine, were investigated. Withdrawal of Ca2+ caused inhibition of both KCl and 5-hydroxytryptamine responses, but the maximum effect of KCl in Ca2(+)-free medium was recuperated by increasing the KCl concentration. The maximum effect of 5-hydroxytryptamine, however, was recuperated only when Ca2+ was restored to the medium. Consistently with an inhibition in Ca2(+)-free medium, calcium entry blockers produced a concentration-dependent relaxation of human umbilical artery strips precontracted with KCl and 5-hydroxytryptamine, and inhibited the concentration-dependent contraction elicited by these stimuli. Our results indicate that contractile responses of the human umbilical arteries are dependent on extracellular Ca2+ for both KCl and 5-hydroxytryptamine. Although Ca2+ entry was sensitive to both nicardipine and nifedipine, the differences between the effects of these dihydropyridines with the two experimental approaches we used were not always conclusive.

Calcium Channel Blockers